A question in plain language. An answer with receipts.
Ask the way you would ask a senior — EvidenceFirst does the retrieval, ranking and citation, and shows its work.
Speak it or type it — wards are noisy
Natural language or keyword shorthand, abbreviations included. Hybrid retrieval reads both, so “ceftriaxone dose pyelo pregnancy” works as well as a full sentence. Voice input for the corridor between beds.
Recent questions · representative
58-year-old, T2DM with CKD (eGFR 38) — safest add-on to metformin?
An SGLT2 inhibitor is preferred at this eGFR, with dose review below 30[1]. Avoid glimepiride dose escalation given hypoglycaemia risk in CKD[2].
- Check eGFR before initiation and at review.
- NLEM lists generic options — cost noted per fill.
Grounded generation, not vibes
Every recommendation must carry a citation that resolves to a retrieved source span — otherwise it is not shown. Answers follow one structure: direct answer, key takeaways, citations, sources and related questions.
Conflicts surfaced. When ICMR and WHO disagree, you see both positions with sources — never a silent average.
Low confidence flagged. Weak evidence gets a warning banner and a source-forward layout instead of a confident summary.
In seconds, then move on
Save an answer to a case, share it with a colleague, or ask the follow-up — context carries across the conversation. Your history and saved answers stay searchable.
Not a mock-up — the product
This is the live answer component from the platform, rendering a real response to a dengue-management query — confidence grading, key takeaways and claim-level citations against ICMR and WHO guidance, exactly as you’ll see it on the ward.
Representative content for illustration · not medical advice.
58-year-old, T2DM with CKD (eGFR 38) — safest add-on to metformin?
An SGLT2 inhibitor is preferred at this eGFR, with dose review below 30[1]. Avoid glimepiride dose escalation given hypoglycaemia risk in CKD[2].
| Task | EvidenceFirst | General chatbot | Textbook + search |
|---|---|---|---|
| Citations | Always — linked to the source passage | Sometimes, sometimes invented | You assemble them yourself |
| Indian formulary | NLEM-native, generics first | US brand-name defaults | Varies by textbook edition |
| Conflicting guidance | Surfaced side by side | Silently picks one | Found only if you read both |
| Weak evidence | Flagged, source-forward | Confident either way | Depends on your appraisal |
| Time to answer | Seconds, structured | Seconds, unverified | 10–20 minutes |
Textbooks and primary literature remain the deeper read — EvidenceFirst is the fastest defensible path to a decision, not a replacement for reading.
Ready for the ward round?
EvidenceFirst is live. Create a free account with your work email and ask your first question in under a minute.
For physicians, residents and students · Free forever